Vitamin K epoxide reductase complex subunit 1 (Vkorc1) haplotype diversity in mouse priority strains
© Kohn et al; licensee BioMed Central Ltd. 2008
Received: 17 September 2008
Accepted: 01 December 2008
Published: 01 December 2008
Polymorphisms in the vitamin K-epoxide reductase complex subunit 1 gene, Vkorc1, could affect blood coagulation and other vitamin K-dependent proteins, such as osteocalcin (bone Gla protein, BGP). Here we sequenced the Vkorc1 gene in 40 mouse priority strains. We analyzed Vkorc1 haplotypes with respect to prothrombin time (PT) and bone mineral density and composition (BMD and BMC); phenotypes expected to be vitamin K-dependent and represented by data in the Mouse Phenome Database (MPD).
In the commonly used laboratory strains of Mus musculus domesticus we identified only four haplotypes differing in the intron or 5' region sequence of the Vkorc1. Six haplotypes differing by coding and non-coding polymorphisms were identified in the other subspecies of Mus. We detected no significant association of Vkorc1 haplotypes with PT, BMD and BMC within each subspecies of Mus. Vkorc1 haplotype sequences divergence between subspecies was associated with PT, BMD and BMC.
Phenotypic variation in PT, BMD and BMC within subspecies of Mus, while substantial, appears to be dominated by genetic variation in genes other than the Vkorc1. This was particularly evident for M. m. domesticus, where a single haplotype was observed in conjunction with virtually the entire range of PT, BMD and BMC values of all 5 subspecies of Mus included in this study. Differences in these phenotypes between subspecies also should not be attributed to Vkorc1 variants, but should be viewed as a result of genome wide genetic divergence.
The warfarin-sensitive vitamin K epoxide reductase enzyme complex (VKOR) converts vitamin K 2,3-epoxide to vitamin K hydroquinone, a required cofactor for the post-translational gamma-carboxylation of several blood coagulation factors and other vitamin K-dependent proteins, such as osteocalcin (bone Gla protein, BGP) and matrix Gla protein (MGP) [1, 2]. MGP has also been found in blood vessel walls and in association with atherosclerotic plaques [3, 4]. The vitamin K epoxide reductase complex subunit 1 gene (Vkorc1) appears to be a critical component of the VKOR [5, 6].
The laboratory mouse is a widely used model organism to study human physiology and medical conditions. Moreover, the Vkorc1 has recently been discussed in the context of gene-drug interactions and disease. For example, genetic polymorphisms in the Vkorc1 could affect anticoagulant therapy with warfarin in humans [7, 8]. Genetic variants in the Vkorc1 have been shown associated with genetically determined resistance to warfarin in rodents [6, 9]. Genetic polymorphisms in the Vkorc1 gene may also affect other vitamin K-dependent reactions, such as bone mineralization and atherosclerotic calcification [10–12]. For example, low VKOR activity may result in lower levels of post-translational gamma-carboxylation of BGP, and, conceivably, reduce the BGP-dependent phenotypic measures bone mineral density (BMD) or bone mineral content (BMC). Osteoporosis-related fractures have been postulated side effects of anticoagulant treatment with warfarin, which inhibits the VKOR .
So-called mouse priority strains currently are subjected to intensive phenotyping surveys. The results of these are accessible via the Mouse Phenome Database (MPD) at the Jackson Laboratory, Bar Harbor, Maine . If genetic variation in the Vkorc1 for the panel of mouse priority strains would be known then searches for possible associations of Vkorc1 haplotypes with simple and complex vitamin K-dependent phenotypic measurements could be initiated. However, so far only 5 Vkorc1 haplotypes have been identified in 16 strains representing 4 subspecies (c.f. MPD, Perlgen data; accessed September 2008).
This shortage of data prompted us to collect genetic polymorphism data for the Vkorc1 gene in mouse priority strains. In addition, we explored patterns of association between Vkorc1 haplotypes and the vitamin K-dependent phenotypes prothrombin time (PT), bone mineral density and content (BMD and BMC) currently available in the MPD.
Discovery of Vkorc1 haplotypes
Sequences were assembled, proofread and aligned to the published sequence of the Vkorc1 of the mouse (C57BL/6J) using LASERGENE 7.2 . Single nucleotide polymorphisms (SNPs) and insertions/deletions (indels) were identified and verified by eye. Haplotypes were inferred by using ARLEQUIN 3.11 .
Phylogenetic analysis of the Vkorc1 haplotypes
Subspecies of the mouse may differ in their phenotypes merely as a function of the genetic differences accrued across the genome during independent evolution. Thus it is important to limit direct tests for association of Vkorc1 haplotypes with phenotypic traits to groups of closely related strains, or clades, of the same subspecies of Mus. We used phylogenetic methods (ignoring recombination) to identify such clades based on the identified Vkorc1 haplotypes.
Specifically, we studied five subspecies of Mus represented by 31 inbred- and 9 wild-derived strains [see Additional file 1]. M. m. domesticus is the commonly used laboratory mouse. M. m. musculus, M. m. spretus, M. m. castaneus and M. m. molossinus are subspecies of Mus that have contributed to varying degrees to the gene pool of some M. m. domesticus strains. To reconstruct the evolutionary relationships between strains neighbor-joining (NJ) and maximum parsimony (MP) trees were built using the option of complete deletion and 1,000 bootstrap replicates as implemented in MEGA 4.0 . Genetic distances underlying the NJ method were corrected by the Kimura 2-parameter model . M. m. spretus (SPRET/EiJ) was used to root the tree [18, 19].
In silico association analyses based on the Mouse Phenome Database (MPD)
Phenotypic measurements PT , BMD  and BMC  for each strain were retrieved from the MPD . The strain PWD/PhJ was excluded for lack of data. STATISTICA 8.0  was used to identify clusters of strains based on each phenotypic measurement (transformed to the city-block/Manhattan linkage distance) by applying the unweighted pair-group method with arithmetic means (UPGMA). We tested for the association of Vkorc1 haplotypes with each phenotypic measurement within and between clades (as defined by phylogenetic analysis) using Mann-Whitney U tests.
Results and discussion
Vkorc1 genetic polymorphisms in mouse priority strains
We identified 10 haplotypes that were defined by 84 SNPs and 153 indels [see Additional file 1]. Six haplotypes were identified when the coding region was considered (Figure 1b). Five non-synonymous SNPs altering five amino acids (R12W, A21T, A26S, A48T and R61L) and four synonymous SNPs were identified (Figure 1b). The C132C polymorphism unique to M. m. musculus mapped onto the evolutionary conserved redox center C132-X-X-C135 motif of the Vkorc1 [24, 25].
Consideration of SNPs and indels in the 5' region increased the number of haplotypes to nine (Figure 1b), and inclusion of intronic polymorphisms increased the number of haplotypes to ten. All M. m. domesticus strains were identical in the coding region but genetic polymorphisms in the 5' region separated M. m. domesticus into two groups (Figure 1b). However, our comprehensive survey uncovered only two previously known Vkorc1 haplotypes (1 and 7) and two novel haplotypes (2 and 8) in M. m. domesticus. Considering the coding and 5' regions, only synonymous SNPs and 5' polymorphisms distinguished M. m. domesticus and M. m. musculus. A single non-synonymous SNP distinguished M. m. domesticus and M. m. musculus from M. m. molossiunus and M. m. castaneus. Four non-synonymous SNPs and at least eight 5' variants were unique to M. m. spretus.
Phylogenetic analysis of Vkorc1 haplotypes
Relationship between Vkorc1 polymorphisms and prothrombin time
Variation in PT within and between clades I-IV was substantial. However, variation in PT within M. m. domesticus (clades I and II) overlapped with PT variation in the other subspecies (Figure 2b). In particular, the mean (and standard deviation) of PT was 10.318 (0.514) for clade I, 10.772 (0.857) for clade II, and 10.345 (0.541) for clades (I + II) (i.e. within M. m. domesticus). The corresponding values for clades III and IV, respectively, were 10.850 (0.451) and 11.075 (0.729).
None of the clusters identified based on PT values for each strain was comprised out of groups of related Vkorc1 haplotypes as defined by the phylogenetic analysis [see Additional file 2]. Most notably, haplotype 1 was observed in conjunction with the entire range of PT values present in the data, and it clustered with a wide range of genetically different haplotypes from various distinct clades. For example, the strains CBA/J (haplotype 1) and JF1/Ms (haplotype 5), which differ by 5' polymorphisms as well as one non-synonymous and two synonymous polymorphisms, clustered together based on their PT values (Figure 1b). Similarly, A/J (haplotype 1) and PWK/PhJ (haplotype 9), which differ in at least 10 polymorphisms in the 5' region and 3 synonymous SNPs, clustered together.
Statistical analysis confirmed this suggested lack of association between PT and Vkorc1 haplotypes within each of the clades I-IV (Mann-Whitney U tests, all N.S. at α = 0.05). Moreover, no significant association was found between haplotypes identified in M. m. domesticus and PT (clades I vs. II) (P = 0.389), suggesting 5' polymorphisms have little if any effect. Even clades differing by a non-synonymous SNP (A21T) as well as 5' polymorphisms did not significantly differ in PT (clades III vs. IV) (P = 0.733). Thus, association between the vitamin K-dependent phenotype PT and haplotype variation of the Vkorc1 was not statistically supported within subspecies and between sister clades of subspecies as defined by the Vkorc1 haplotype tree.
However, the genetic distance between Vkorc1 haplotypes accrued between more divergent subspecies was correlated with differences in PT (clades I vs. III; P = 0.022) and (clades I vs. IV; P = 0.006). However, given the large number of mutations across the genome separating these clades, this association is, in our view, not an indication of an association between Vkorc1 haplotypes and variation in PT between clades.
Relationship between Vkorc1 polymorphisms and bone mineralization
Similar to the results for PT variation in BMD within and between clades I-IV was substantial (Figure 2b), with the entire range of variation present in M. m. domesticus (clades 1+II). In particular, the mean (and standard deviation) of BMD was 0.055 (0.005) for clade I, 0.053 (0.005) for clade II, and 0.054 (0.005) for clades (I + II) (i.e. within M. m. domesticus). The corresponding values for clades III and IV, respectively, were 0.046 (0.001) and 0.046 (0.002). A similar pattern was observed for BMC (Figure 2b).
Analysis of BMD and BMC values resulted in two major clusters [c.f. Additional file 2]. One major cluster was comprised out of the M. m. domesticus haplotypes 1, 2, and 7. The other major cluster included a wide range of genetically different haplotypes from all subspecies of Mus, suggesting that there is no clear association of Vkorc1 haplotypes with BMD and BMC values. For instance, haplotype 1, which was found in conjunction with the entire range of BMD and BMC values, also clustered together with SPRET/EiJ (haplotype 10) based on BMD. However, these two haplotypes differ by as many as 4 non-synonymous SNPs and 21 polymorphisms in the 5' region (Figure 1b).
Statistical analysis confirmed this suggested lack of association between BMD and BMC and Vkorc1 haplotypes within each of the clades I-IV (Mann-Whitney U tests, all N.S. at α = 0.05). Moreover, no significant association was found between haplotypes identified in M. m. domesticus and BMD and BMC (clade I vs. II) (P = 0.510 for BMD and P = 0.582 for BMC) suggesting 5' polymorphisms have little if any effect on the phenotypes. Even clades differing by a non-synonymous SNP (A21T) as well as 5' polymorphisms did not significantly differ in BMD and BMC (clade III vs. IV) (P = 0.671 for BMD and P = 0.497 for BMC). Thus, within subspecies or between closely related subspecies no association between the vitamin K dependent phenotypes BMD and BMC and haplotype variation of the Vkorc1 was found.
However, when genetically more divergent clades were compared an association of Vkorc1 haplotypes with BMD and BMC was observed (clade I vs. III; P < 0.001 for BMD and P = 0.001 for BMC and clade I vs. IV; P < 0.001 for BMD and P = 0.001 for BMC). However, as discussed above for PT, this association should not be interpreted as direct evidence for the role of the Vkorc1 in determining BMD and BMC.
The comprehensive SNP survey covering the Vkorc1 and its 5' flanking region of 40 mouse priority strains should be a valuable resource for future tests of an association between vitamin K-dependent phenotypes and Vkorc1 haplotypes. For example, the absence of Vkorc1 haplotype variation in M. m. domesticus in clade I enables a rapid assessment of the role of the Vkorc1 underlying variation in a phenotype. However, in this study, variation of PT, BMD and BMC could not be explained by Vkorc1 haplotype, as evidenced in particular by the range of phenotypic variation seen in conjunction with M. m. domesticus haplotype 1.
Contrasts between M. m. domesticus strains of clade I and II may be informative with regard the role of polymorphisms in the 5' region of the Vkorc1. In our study of PT, BMD and BMC, however, this 5' sequence variation of the Vkorc1 did not significantly explain the variation in these phenotypes. We note that only two strains currently belong to clade II, which precluded more powerful statistical tests for association. Additional strains belonging to this clade should be identified.
Overall, phenotypic variation in PT, BMD and BMC in M. m. domesticus, which is substantial, appears to be dominated by genetic variation in genes other than the Vkorc1. Phenotypic differences between subspecies should be interpreted as a byproduct of genome wide divergence. We suggest that it would be of interest to measure differences in warfarin tolerance between mouse priority strains, particular, between strains belonging to clades I and II, because warfarin tolerance in humans and warfarin resistance in rodents had been attributed to Vkorc1 haplotype variation. In addition, MGP is a vitamin K-dependent protein that is a potent inhibitor of the calcification of the cardiovascular system. Thus, it would be of interest to examine the degree to which the calcification of the cardiovascular system is associated with Vkorc1 haplotypes in mouse priority strains belonging to clades I and II. However, in the current panel of the common laboratory mouse priority strains of M. m. domesticus most variation in potentially vitamin K-dependent phenotypes appears to be due to variation in genes other than the Vkorc1.
We thank anonymous reviewers for helpful comments. This work was funded in part by a Hamill innovation grant from the Institute of Biosciences and Bioengineering, Rice University, and by grant R01 HL091007 from the National Heart, Lung, and Blood Institute (NHLBI) to MHK.
- Presnell SR, Stafford DW: The vitamin K-dependent carboxylase. Thromb Haemost. 2002, 87 (6): 937-946.PubMed
- Wallin R, Hutson SM, Cain D, Sweatt A, Sane DC: A molecular mechanism for genetic warfarin resistance in the rat. Faseb J. 2001, 15 (13): 2542-2544.PubMed
- Canfield AE, Farrington C, Dziobon MD, Boot-Handford RP, Heagerty AM, Kumar SN, Roberts IS: The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol. 2002, 196 (2): 228-234. 10.1002/path.1020.View ArticlePubMed
- Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994, 93 (6): 2393-2402. 10.1172/JCI117246.PubMed CentralView ArticlePubMed
- Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW: Identification of the gene for vitamin K epoxide reductase. Nature. 2004, 427 (6974): 541-544. 10.1038/nature02254.View ArticlePubMed
- Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, Pelz HJ, Lappegard K, Seifried E, Scharrer I, Tuddenham EG, et al: Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature. 2004, 427 (6974): 537-541. 10.1038/nature02214.View ArticlePubMed
- Limdi NA, Arnett DK, Goldstein JA, Beasley TM, McGwin G, Adler BK, Acton RT: Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans. Pharmacogenomics. 2008, 9 (5): 511-526. 10.2217/146224126.96.36.1991.PubMed CentralView ArticlePubMed
- Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, Shimomura H, Wanibuchi Y, Suzuki T, Kamatani N, et al: Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet. 2006, 51 (3): 249-253. 10.1007/s10038-005-0354-5.View ArticlePubMed
- Pelz HJ, Rost S, Hunerberg M, Fregin A, Heiberg AC, Baert K, MacNicoll AD, Prescott CV, Walker AS, Oldenburg J, et al: The genetic basis of resistance to anticoagulants in rodents. Genetics. 2005, 170 (4): 1839-1847. 10.1534/genetics.104.040360.PubMed CentralView ArticlePubMed
- Erkkila AT, Booth SL: Vitamin K intake and atherosclerosis. Curr Opin Lipidol. 2008, 19 (1): 39-42.View ArticlePubMed
- Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, Dawson-Hughes B, Wilson PW, Cupples LA, Kiel DP: Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr. 2003, 77 (2): 512-516.PubMed
- Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O'Fallon WM, Castro MR, Melton Iii LJ: Long-term Use of Oral Anticoagulants and the Risk of Fracture. Arch Intern Med. 1999, 159 (15): 1750-1756. 10.1001/archinte.159.15.1750.View ArticlePubMed
- The Jackson Laboratory. [http://www.jax.org/]
- Burland TG: DNASTAR's Lasergene sequence analysis software. Methods Mol Biol. 2000, 132: 71-91.PubMed
- Excoffier L, Laval G, Schneider S: Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online. 2005, 1: 47-50.PubMed Central
- Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24 (8): 1596-1599. 10.1093/molbev/msm092.View ArticlePubMed
- Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980, 16 (2): 111-120. 10.1007/BF01731581.View ArticlePubMed
- Salcedo T, Geraldes A, Nachman MW: Nucleotide variation in wild and inbred mice. Genetics. 2007, 177 (4): 2277-2291. 10.1534/genetics.107.079988.PubMed CentralView ArticlePubMed
- Prager EM, Orrego C, Sage RD: Genetic variation and phylogeography of central Asian and other house mice, including a major new mitochondrial lineage in Yemen. Genetics. 1998, 150 (2): 835-861.PubMed CentralPubMed
- Peters LL, Baker JE: Hematology, clotting, and thrombosis. MPD: 62. Mouse Phenome Database Web Site, The Jackson Laboratory, Bar Harbor, Maine USA. World Wide Web. 2008, [http://www.jax.org/phenome]
- Tordoff MG, Bachmanov AA: Survey of calcium & sodium intake and metabolism with bone and body composition data. MPD:103. Mouse Phenome Database Web Site, The Jackson Laboratory, Bar Harbor, Maine USA. World Wide Web. 2008, [http://www.jax.org/phenome]
- Mouse Phenome Database. [http://www.jax.org/phenome]
- StatSoft, Inc.: STATISTICA (data analysis software system), version 8.0. [http://www.statsoft.com]
- Rost S, Fregin A, Hunerberg M, Bevans CG, Muller CR, Oldenburg J: Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. Thromb Haemost. 2005, 94 (4): 780-786.PubMed
- Wang J, Feng Z, Yao D, Sui J, Zhong W, Li M, Dai J: Warfarin resistance in Rattus losea in Guangdong Province, China. Pestic Biochem Physiol. 2008, 91 (2): 90-95. 10.1016/j.pestbp.2008.01.007.View Article
- Liu YH, Takahashi A, Kitano T, Koide T, Shiroishi T, Moriwaki K, Saitou N: Mosaic genealogy of the Mus musculus genome revealed by 21 nuclear genes from its three subspecies. Genes Genet Syst. 2008, 83 (1): 77-88. 10.1266/ggs.83.77.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.